July 17, 2017

Take Action! Tuesday, July 18, is National HIV Call-In Day!

We know we have asked you to do a lot over the last several months. You have faithfully called Congress time and again to tell them […]
May 16, 2017
ibalizumab HIV

Ibalizumab: First Long Acting HIV Treatment Available Now Via Expanded Access

No one can deny that many patients can now suppress their HIV with effective antiretrovirals (ARVs) that cause fewer side effects. However, a vulnerable and often […]
May 15, 2017

Probiotic Visbiome improves gut barrier function in patients with HIV

“Probiotic supplementation improved the physical and immunological integrity of the intestinal mucosal barrier in HIV-1-positive patients being treated with antiretroviral therapy, according to new research.   […]
May 15, 2017

New HIV Drugs in the Pipeline- 2017: CROI Review by Dr Pablo Tebas

Gilead presented some data about a new capsid formation inhibitor (GS-CA1), a total new drug class that looks incredibly powerful in vitro (6) [ CROI: Discovery […]